Is ENTA A Good Stock To Buy Now According To Hedge Funds?
In this article we will check out the progression of hedge fund sentiment towards Enanta Pharmaceuticals Inc (NASDAQ:ENTA) and determine whether it is a good investment right ...
Posts Tagged ‘NASDAQ:ENTA’
Is Enanta Pharmaceuticals Inc (ENTA) Going to Burn These Hedge Funds?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Were Hedge Funds Right About Ditching Enanta Pharmaceuticals Inc (ENTA)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Hedge Funds Are Selling Enanta Pharmaceuticals Inc (ENTA)
In this article we will take a look at whether hedge funds think Enanta Pharmaceuticals Inc (NASDAQ:ENTA) is a good investment right now.
Were Hedge Funds Right About Enanta Pharmaceuticals Inc (ENTA)?
Hedge funds don't get the respect they used to get. Nowadays investors prefer passive funds over actively managed funds.
Is Enanta Pharmaceuticals Inc (ENTA) A Good Stock To Buy?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
Enanta Pharmaceuticals Inc (ENTA): Hedge Funds In Wait-and-See Mode
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th.
Here’s What Hedge Funds Think About Enanta Pharmaceuticals Inc (ENTA)
Is Enanta Pharmaceuticals Inc (NASDAQ:ENTA) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the...
Here is What Hedge Funds Think About Enanta Pharmaceuticals Inc (ENTA)
Is Enanta Pharmaceuticals Inc (NASDAQ:ENTA) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research.
Hedge Funds Are Crazy About Enanta Pharmaceuticals Inc (ENTA)
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable...
These Are Apex Capital Management’s Top Biotech Stock Picks
Founded in 1987, Apex Capital Management invests mainly in companies that have market caps of up to $10 billion and is currently overseeing $6.5 billion in assets under management...
Akorn, Inc. (AKRX), United Therapeutics Corporation (UTHR) Among Consonance Capital’s Winning Bets in Healthcare
The $5.50 billion pharmaceutical company Akorn, Inc. (NASDAQ:AKRX) was one of the top gainers on Wednesday, closing the session with an almost 10% gain.
Apple Inc. (AAPL), BioDelivery Sciences International Inc. (BDSI) Among Thomas Bailard’s Top Q2 Top Picks
Thomas Bailard is the co-founder and current manager of Bailard Inc. Located in California, Bailard uses quantitative and fundamental analyses to choose its investments.
Consonance Capital Management is Fond of Healthcare Stocks
Consonance Capital Management is a New York based hedge fund established in 2005, managed by Mitchell Blutt MD.
Ra Capital Management Reveals New Stake in Enanta Pharmaceuticals Inc (ENTA)
Peter Kolchinsky's Ra Capital Management disclosed a new position in Enanta Pharmaceuticals Inc (NASDAQ:ENTA).
Netflix, Inc. (NFLX) Just One of Three Stocks With Upgrades That Moved Against the Market
It was hard to find a stock that traded higher on Monday as the market was pushed significantly lower following disappointing data from China and a hit in the gold market.
